BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR, Zafari P, Esmaeili SA. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life 2020;72:2366-81. [PMID: 33006813 DOI: 10.1002/iub.2387] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Li C, Ren G, Yang C, Sun J, Zhao L, Sun W, Ju J, Xu D. Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus. Autoimmunity Reviews 2022. [DOI: 10.1016/j.autrev.2022.103213] [Reference Citation Analysis]
2 Xiang S, Zhang J, Zhang M, Qian S, Wang R, Wang Y, Xiang Y, Ding X. Imbalance of helper T cell type 1, helper T cell type 2 and associated cytokines in patients with systemic lupus erythematosus: A meta-analysis. Front Pharmacol 2022;13:988512. [DOI: 10.3389/fphar.2022.988512] [Reference Citation Analysis]
3 Shakerian L, Kolahdooz H, Garousi M, Keyvani V, Kamal Kheder R, Abdulsattar Faraj T, Yazdanpanah E, Esmaeili SA. IL-33/ST2 axis in autoimmune disease. Cytokine 2022;158:156015. [PMID: 36041312 DOI: 10.1016/j.cyto.2022.156015] [Reference Citation Analysis]
4 Shandil RK, Dhup S, Narayanan S, Mishra R. Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases. Stem Cells International 2022;2022:1-8. [DOI: 10.1155/2022/6379161] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Mahmoudi M, Hoseinzadeh A, Rezaieyazdi Z, Afshari JT, Mahmoudi A, Heydari S. Cross Talk between Mesenchymal Stem/Stromal Cells and Innate Immunocytes Concerning Lupus Disease. Stem Cell Rev and Rep. [DOI: 10.1007/s12015-022-10397-x] [Reference Citation Analysis]
6 Yuan C. IL-33 in autoimmunity; possible therapeutic target. International Immunopharmacology 2022;108:108887. [DOI: 10.1016/j.intimp.2022.108887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Quaglia M, Merlotti G, Fornara L, Colombatto A, Cantaluppi V. Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis. Int J Mol Sci 2022;23:5760. [PMID: 35628570 DOI: 10.3390/ijms23105760] [Reference Citation Analysis]
8 Bagheri V, Esmaeili SA, Gholamin M, Abbaszadegan MR. Rapid Isolation of Gastric Adenocarcinoma Cancer Stem Cells as a Target for Autologous Dendritic Cell-Based Immunotherapy. Iran J Biotechnol 2022;20:e3045. [PMID: 36337066 DOI: 10.30498/ijb.2021.284841.3045] [Reference Citation Analysis]
9 Mobasheri L, Hossein Nasirpour M, Masoumi E, Foolady Azarnaminy A, Jafari M, Esmaeili S. SARS-CoV-2 triggering autoimmune diseases. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
10 Xu C, Wu Y, Liu N. Osteopontin in autoimmune disorders: current knowledge and future perspective. Inflammopharmacology 2022. [PMID: 35235108 DOI: 10.1007/s10787-022-00932-0] [Reference Citation Analysis]
11 Wang J, Gong M, Fan X, Huang D, Zhang J, Huang C. Autophagy-related signaling pathways in non-small cell lung cancer. Mol Cell Biochem 2021. [PMID: 34757567 DOI: 10.1007/s11010-021-04280-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Esmaeili SA, Taheri RA, Mahmoudi M, Momtazi-Borojeni AA, Morshedi M, Bahramifar A, Fasihi-Ramandi M. Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs. Iran J Basic Med Sci 2021;24:1509-14. [PMID: 35317107 DOI: 10.22038/IJBMS.2021.58438.12982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathol Res Pract 2021;227:153641. [PMID: 34619575 DOI: 10.1016/j.prp.2021.153641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
14 Hassanshahi G, Roohi MA, Esmaeili SA, Pourghadamyari H, Nosratabadi R. Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal stem cells in multiple sclerosis patients. Cytokine 2021;148:155706. [PMID: 34583254 DOI: 10.1016/j.cyto.2021.155706] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther 2021;12:469. [PMID: 34419143 DOI: 10.1186/s13287-021-02542-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Yuan J, Wei Z, Xu X, Ocansey DKW, Cai X, Mao F. The Effects of Mesenchymal Stem Cell on Colorectal Cancer. Stem Cells Int 2021;2021:9136583. [PMID: 34349805 DOI: 10.1155/2021/9136583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Nourbakhsh E, Mohammadi A, Salemizadeh Parizi M, Mansouri A, Ebrahimzadeh F. Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target. Inflammopharmacology 2021. [PMID: 34283371 DOI: 10.1007/s10787-021-00846-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 He J, Ping S, Yu F, Yuan X, Wang J, Qi J. Mesenchymal stem cell-derived exosomes: therapeutic implications for rotator cuff injury. Regen Med 2021;16:803-15. [PMID: 34261369 DOI: 10.2217/rme-2020-0183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang X, He Z, Zhao X. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review). Exp Ther Med 2021;21:319. [PMID: 33732292 DOI: 10.3892/etm.2021.9750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]